KR102171334B1 - Composition for improving skin condition containing a fermented soybean - Google Patents
Composition for improving skin condition containing a fermented soybean Download PDFInfo
- Publication number
- KR102171334B1 KR102171334B1 KR1020200030880A KR20200030880A KR102171334B1 KR 102171334 B1 KR102171334 B1 KR 102171334B1 KR 1020200030880 A KR1020200030880 A KR 1020200030880A KR 20200030880 A KR20200030880 A KR 20200030880A KR 102171334 B1 KR102171334 B1 KR 102171334B1
- Authority
- KR
- South Korea
- Prior art keywords
- fermented
- skin
- yak
- extract
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 56
- 244000068988 Glycine max Species 0.000 title claims description 55
- 235000010469 Glycine max Nutrition 0.000 title claims description 55
- 230000006872 improvement Effects 0.000 claims abstract description 34
- 230000037303 wrinkles Effects 0.000 claims abstract description 31
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 21
- 230000008591 skin barrier function Effects 0.000 claims abstract description 6
- 238000005728 strengthening Methods 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 52
- 239000000047 product Substances 0.000 claims description 49
- 239000000284 extract Substances 0.000 claims description 39
- 239000002537 cosmetic Substances 0.000 claims description 27
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 24
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 24
- 238000000855 fermentation Methods 0.000 claims description 22
- 230000004151 fermentation Effects 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 235000013305 food Nutrition 0.000 claims description 17
- 239000004480 active ingredient Substances 0.000 claims description 14
- 239000003963 antioxidant agent Substances 0.000 claims description 10
- 230000002401 inhibitory effect Effects 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 230000037319 collagen production Effects 0.000 claims 1
- 239000012046 mixed solvent Substances 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 30
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract description 22
- 239000004310 lactic acid Substances 0.000 abstract description 11
- 235000014655 lactic acid Nutrition 0.000 abstract description 11
- 241000894006 Bacteria Species 0.000 abstract description 10
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 abstract description 7
- 241000913743 Rhynchosia Species 0.000 abstract 3
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 47
- 244000046052 Phaseolus vulgaris Species 0.000 description 42
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 42
- 235000019441 ethanol Nutrition 0.000 description 33
- 238000000605 extraction Methods 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000000243 solution Substances 0.000 description 14
- 229940069765 bean extract Drugs 0.000 description 13
- -1 pH adjusters Substances 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 230000009467 reduction Effects 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 102000029816 Collagenase Human genes 0.000 description 8
- 108060005980 Collagenase Proteins 0.000 description 8
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 8
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 8
- 235000013361 beverage Nutrition 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 239000008194 pharmaceutical composition Substances 0.000 description 8
- 229960002424 collagenase Drugs 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000006071 cream Substances 0.000 description 6
- 210000002510 keratinocyte Anatomy 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241001107116 Castanospermum australe Species 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 235000021279 black bean Nutrition 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000469 ethanolic extract Substances 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 229960003471 retinol Drugs 0.000 description 4
- 235000020944 retinol Nutrition 0.000 description 4
- 239000011607 retinol Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 235000020712 soy bean extract Nutrition 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000238424 Crustacea Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 102000006995 beta-Glucosidase Human genes 0.000 description 2
- 108010047754 beta-Glucosidase Proteins 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000378 calcium silicate Substances 0.000 description 2
- 229910052918 calcium silicate Inorganic materials 0.000 description 2
- 235000012241 calcium silicate Nutrition 0.000 description 2
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 239000003889 eye drop Substances 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 241000283080 Proboscidea <mammal> Species 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000002038 chemiluminescence detection Methods 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229940021231 clearskin Drugs 0.000 description 1
- 230000011382 collagen catabolic process Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 230000007269 microbial metabolism Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229930188627 soysaponin Natural products 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Sustainable Development (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
약콩 발효물을 함유하는 피부 개선용 화장료 조성물, 식품 조성물, 사료 조성물, 및 약학 조성물에 관한 것이다.It relates to a cosmetic composition for skin improvement, a food composition, a feed composition, and a pharmaceutical composition containing a fermented soybean product.
레티놀은 피부 주름개선 기능성 소재로 사용하는 가장 대표적인 성분이다. 레티놀은 자외선으로 인한 콜라겐 분해를 억제하고, 동시에 새로운 콜라겐 형성을 촉진하여 효과적인 주름 개선 효능을 갖는다. 그러나, 레티놀은 매우 불안정한 화학물질로, 함유량이 높아질 경우 불안정성이 높아지고, 공기에 노출될 경우 효능이 떨어지는 문제가 있다. 또한, 햇빛에 의해 피부에 자극적인 화학물질로 분해되기 때문에 밤에만 사용해야 하는 한계점이 있다. 이로 인해, 레티놀이 함유된 화장품을 사용한 10명 중 9명은 피부 건조증, 홍조, 각화 등의 부작용을 경험한 것으로 알려져 있다. 이러한 이유로, 소비자들은 주름 개선의 새로운 대체 소재를 필요로 하고, 특히, 피부의 미용과 건강에 관한 관심이 증가하면서 피부 개선을 위한 기능성 물질의 높은 효능만을 추구하는 것이 아니라, 인체에 무해하고, 부작용 등의 위험성을 배제할 수 있는 소재를 추구하고 있다. 나아가, 천연 화장품, 유기농 화장품, 반 동물실험 화장품을 원하는 글로벌 소비 트렌드가 형성되고 있다. Retinol is the most representative ingredient used as a functional material for skin wrinkle improvement. Retinol inhibits collagen degradation due to ultraviolet rays and at the same time promotes the formation of new collagen and has an effective wrinkle improvement effect. However, retinol is a very unstable chemical, and when its content is high, its instability increases, and when it is exposed to air, its efficacy is poor. In addition, since it is decomposed into chemical substances that are irritating to the skin by sunlight, there is a limitation that it must be used only at night. For this reason, it is known that 9 out of 10 people who used cosmetics containing retinol experienced side effects such as dry skin, redness, and keratinization. For this reason, consumers are in need of new alternative materials for wrinkle improvement, and in particular, as interest in skin beauty and health increases, not only seeking high efficacy of functional substances for skin improvement, but harmless to the human body, and side effects. We are pursuing materials that can exclude the danger of such as. Furthermore, a global consumption trend that wants natural cosmetics, organic cosmetics, and anti-animal cosmetics is forming.
한편, 다양한 천연 화장품의 소재 중에서도 콩은 지방 함유량이 18% 정도인데, 이들 대부분이 불포화 지방산이며, 이 중 절반 이상이 리놀렌산이다 (Kim YH, Hawrylewiez EJ 등, 1992, Klein BP 등 1995, Sirtori CR 등 1995). 그 밖에 아이소플라본류, 콩 사포닌, 올리고당류 등 기능성 성분이 다량 함유되어 있다 (Kennedy AR 1995). 콩의 다양한 종류 중에서도 쥐눈이콩은 예로부터 약리적 효능이 뛰어나 약콩으로 불렸으며, 한의학서적 본초강목에서는 해독 효과가 뛰어난 약재로 소개하고 있다. 이러한 약콩은 필수아미노산 40%를 포함하고, 비타민 E, 카로티노이드, 사포닌, 안토시아닌 등의 항산화 물질을 일반 콩에 비해 4배 더 많은 양으로 함유하고 있다. 최근 연구에 따르면, 혈액 순환, 간 기능을 보호하는 약리기전과 더불어, 노인성 치매를 예방하고, 신장 기능을 향상시키는 것으로 보고된 바 있다 (Kim MH 등, 2008). 이러한 약콩의 효능으로 인해 건강기능성식품, 화장료 조성물의 유효성분으로 다양하게 활용되고 있다.On the other hand, among the materials of various natural cosmetics, soybeans contain about 18% fat, most of which are unsaturated fatty acids, of which more than half is linolenic acid (Kim YH, Hawrylewiez EJ, 1992, Klein BP, 1995, Sirtori CR, etc. 1995). In addition, it contains a large amount of functional ingredients such as isoflavones, soy saponins, and oligosaccharides (Kennedy AR 1995). Among the various types of beans, barren bean has been called Yak-bean because of its excellent pharmacological efficacy from ancient times, and it is introduced as a medicinal with excellent detoxification effect in the herbal medicine book. These weak soybeans contain 40% of essential amino acids and contain antioxidants such as vitamin E, carotenoids, saponins, and anthocyanins in an amount 4 times more than that of regular soybeans. According to recent studies, it has been reported to prevent senile dementia and improve kidney function, along with pharmacological mechanisms that protect blood circulation and liver function (Kim MH et al., 2008). Due to the efficacy of these medicinal beans, they are used in various ways as an active ingredient in health functional foods and cosmetic compositions.
이러한 배경 하에, 본 발명자들은 약콩의 효능을 극대화하기 위해 노력한 결과, 약콩을 한국인 영유아 장내 유래 유산균 (Bifidobacterium animalis subsp. Lactis LDTM 8102)을 이용하여 발효시킬 경우 피부 개선 및 항산화 효능이 현저히 증대됨을 확인하여 본 발명을 완성하였다.Under this background, the present inventors have made efforts to maximize the efficacy of Yak Soy . As a result, when fermenting Yak Soy with lactic acid bacteria ( Bifidobacterium animalis subsp. Lactis LDTM 8102) derived from Korean infants and young children, it was confirmed that skin improvement and antioxidant efficacy were remarkably increased. The present invention has been completed.
일 양상은 약콩에 비피도박테리움 애니멀리스 서브스페시스 락티스(Bifidobacterium animalis subsp. Lactis.) LDTM 8102 (KCTC13392BP) 균주를 접종하여 발효시킨, 약콩 발효물을 유효성분으로 함유하는 피부 주름 개선용 화장료 조성물을 제공하는 것이다. One aspect is a cosmetic for improving skin wrinkles containing fermented soybean fermented product, which is fermented by inoculating Yak bean with Bifidobacterium animalis subsp. Lactis. LDTM 8102 (KCTC13392BP) strain as an active ingredient. It is to provide a composition.
다른 양상은 약콩에 비티도박테리움 애니멀리스 서브스페시스 락티스 LDTM 8102 (KCTC13392BP) 균주를 접종하여 발효시킨, 약콩 발효물을 유효성분으로 함유하는 피부 주름 개선용 식품 조성물을 제공하는 것이다.Another aspect is to provide a food composition for improving skin wrinkles containing fermented soybeans as an active ingredient, fermented by inoculating and fermenting a strain of Vitidobacterium animalis subspecs lactis LDTM 8102 (KCTC13392BP) in Yak Kong.
다른 양상은 약콩에 비티도박테리움 애니멀리스 서브스페시스 락티스 LDTM 8102 (KCTC13392BP) 균주를 접종하여 발효시킨, 약콩 발효물을 유효성분으로 함유하는 피부 주름 개선용 사료 조성물을 제공하는 것이다.Another aspect is to provide a feed composition for improving skin wrinkles containing fermented soybeans as an active ingredient, fermented by inoculating and fermenting a strain of Vitidobacterium animalis subspecis lactis LDTM 8102 (KCTC13392BP) in Yak Kong.
다른 양상은 약콩에 비티도박테리움 애니멀리스 서브스페시스 락티스 LDTM 8102 (KCTC13392BP) 균주를 접종하여 발효시킨, 약콩 발효물을 유효성분으로 함유하는 피부 주름 개선용 약학 조성물을 제공하는 것이다.Another aspect is to provide a pharmaceutical composition for improving skin wrinkles containing fermented soybeans as an active ingredient, fermented by inoculating and fermenting a strain of Vitidobacterium animalis subspecis lactis LDTM 8102 (KCTC13392BP) in Yak Kong.
일 양상은 약콩에 비티도박테리움 애니멀리스 서브스페시스 락티스(Bifidobacterium animalis subsp. Lactis.) LDTM 8102 (KCTC13392BP) 균주를 접종하여 발효시킨, 약콩 발효물을 유효성분으로 함유하는 피부 개선용 화장료 조성물을 제공한다. One aspect is a cosmetic composition for skin improvement containing fermented soybean fermented product by inoculating and fermenting the Bifidobacterium animalis subsp.Lactis. LDTM 8102 (KCTC13392BP) strain in Yak Soybean as an active ingredient Provides.
본 명세서 내 용어, “약콩”은 껍질이 까맣고 크기는 보통 검은콩보다 작은 소립 검정콩을 말하며, 쥐눈이콩, 소청자, 약선콩, 다원콩, 소청 2호 등이 있으며 보통 검은콩보다 훨씬 작지만, 이소플라본 계열 유용성분인 제니스테인(genistein)과 다이드제인(daidzein)이 다른 검은 콩 보다 월등히 많이 포함되어 있다.In this specification, the term “Yakkong” refers to small black beans with a black skin and smaller than ordinary black beans, and there are bark beans, Socheongja, Yakseon beans, Dawon beans, Socheong No. 2, etc., which are much smaller than ordinary black beans, but iso The flavone series of useful ingredients, genistein and daidzein, are contained far more than other black beans.
상기 약콩은 발효 전, 전처리된 것일 수 있다. 구체적으로, 상기 약콩은 로스팅(roasting), 또는 분쇄를 수행하여 전처리된 것일 수 있다. 일 구체예에서, 상기 전처리가 로스팅인 경우, 상기 로스팅은 100 내지 300℃의 온도 조건에서, 5 내지 30 분 동안 수행된 것일 수 있다. 구체적으로, 상기 로스팅은 100 내지 300℃, 100 내지 250℃, 100 내지 200℃, 100 내지 150℃, 150 내지 300℃, 150 내지 250℃, 150 내지 200℃, 200 내지 300℃, 160 내지 300℃ 또는 160 내지 250℃의 조건에서 수행된 것일 수 있다. 또한, 상기 로스팅은 5 내지 30 분, 5 내지 25 분, 5 내지 20 분, 5 내지 15 분, 5 내지 10 분, 7 내지 30 분, 7 내지 20 분, 또는 10 내지 30 분 동안 수행된 것일 수 있다. 이때, 로스팅 온도가 상기 범위 미만인 경우, 약콩의 향미가 유지되지 못하고, 피부 개선 효능이 저하되는 문제점이 있으며, 상기 범위를 초과하는 경우, 약콩의 쓴맛이 강해지는바, 소비자 선호도가 감소하는 문제점이 있다. 또한, 로스팅 시간이 상기 범위 미만인 경우, 식품조성물로 적용할 경우 맛의 안정성이 유지되지 못하는 문제점이 있으며, 상기 범위를 초과하는 경우, 약콩이 탄화되는 문제점이 있다.The yak bean may be pre-treated before fermentation. Specifically, the yak bean may be pretreated by performing roasting or grinding. In one embodiment, when the pretreatment is roasting, the roasting may be performed for 5 to 30 minutes at a temperature condition of 100 to 300°C. Specifically, the roasting is 100 to 300°C, 100 to 250°C, 100 to 200°C, 100 to 150°C, 150 to 300°C, 150 to 250°C, 150 to 200°C, 200 to 300°C, 160 to 300°C Alternatively, it may be performed under conditions of 160 to 250°C. In addition, the roasting may be performed for 5 to 30 minutes, 5 to 25 minutes, 5 to 20 minutes, 5 to 15 minutes, 5 to 10 minutes, 7 to 30 minutes, 7 to 20 minutes, or 10 to 30 minutes. have. At this time, when the roasting temperature is less than the above range, there is a problem in that the flavor of the yak bean is not maintained and the skin improvement effect is deteriorated.If the roasting temperature is exceeded, the bitter taste of the yak bean becomes strong, and consumer preference decreases. have. In addition, when the roasting time is less than the above range, there is a problem that taste stability is not maintained when applied as a food composition, and when it exceeds the above range, there is a problem that the weak beans are carbonized.
본 명세서 내 용어, "비피도박테리움 애니멀리스 서브스페시스 락티스(Bifidobacterium animalis subsp. Lactis.) LDTM 8102 (KCTC13392BP) 균주"는 한국인 영유아의 분변으로부터 분리된 것으로서, 베타-글루코시다아제(β-glucosidase)의 생산 능력이 우수한 바, 쌀, 보리, 우유, 콩, 인삼 등과 해조류, 목질계 등을 포함하는 바이오매스 천연물에 대해 미생물 대사를 통해 유용물질로 생물 전환하는데 효과적으로 이용될 수 있다. As used herein, the term " Bifidobacterium animalis subsp. Lactis.) LDTM 8102 (KCTC13392BP) strain" is isolated from feces of Korean infants and young children, and beta-glucosidase (β- glucosidase) is excellent in production capacity, so it can be effectively used for biotransformation into useful substances through microbial metabolism for natural biomass products including rice, barley, milk, soybeans, ginseng, seaweeds, woody, etc.
본 명세서 내 용어, "발효물"은 유산균을 이용하여 원재료를 물리적, 화학적인 방법으로 변성 또는 변형시키는 것을 의미하며, 자연 하에서는 몇 만년이 걸려야 바뀔 수 있는 것을 단 며칠 또는 몇 개월 만에 원하는 결과물을 얻을 수 있는 분해 과정을 의미한다. 구체적으로, 상기 발효물은 약콩을 유산균 배양배지에 혼합하고 유산균을 접종 및 발효시켜 생산된 발효산물로서, 상기 유산균은 비피도박테리움 애니멀리스 서브스페시스 락티스(Bifidobacterium animalis subsp. Lactis.) LDTM 8102 (KCTC13392BP) 균주인 것일 수 있다. The term "fermented product" in the present specification means that raw materials are denatured or transformed in a physical or chemical way using lactic acid bacteria, and in nature, the desired result is obtained in just a few days or months that can be changed in tens of thousands of years. It refers to the decomposition process that can be obtained. Specifically, the fermentation product is a fermentation product produced by mixing Yak bean into a lactic acid bacteria culture medium, inoculating and fermenting lactic acid bacteria, and the lactic acid bacteria are Bifidobacterium animalis subsp. Lactis. LDTM 8102 (KCTC13392BP) may be a strain.
상기 발효물은 상기 유산균에 의해 발효된 산물을 의미할 뿐만 아니라 약콩을 유산균으로 발효시킨 후 여과한 발효 여과물 또는 발효물을 용매로 추출한 발효 추출물을 포함하는 것일 수 있다. The fermentation product may refer not only to a product fermented by the lactic acid bacteria, but may include a fermentation filtrate or a fermentation extract obtained by extracting the fermented product from the fermented soybean as a solvent.
본 명세서 내 용어, "발효 추출물"은 상기 발효물을 추출하여 생성된 유용한 물질 자체를 의미할 수 있으며, 보다 구체적으로 발효 균주 및 발효물이 공존하는 발효 균주 배양 배지로부터 발효 균주를 원심분리하여 제거한 발효물, 상기 배양 배지로부터 발효 균주를 여과시킨 발효물, 상기 배양 배지로부터 발효 균주를 멸균 처리하고 이를 여과시킨 발효물, 상기 발효물을 희석시킨 희석액, 상기 발효물을 건조시킨 건조물을 추출하여 생성된 물질을 모두 포함할 수 있다. 본 명세서 내에서 용어 발효 추출물은 약콩 발효 추출물과 혼용될 수 있다.In the present specification, the term "fermentation extract" may refer to a useful substance itself produced by extracting the fermentation product, and more specifically, the fermentation strain and the fermentation product are removed by centrifugation from the fermentation strain culture medium coexisting A fermented product, a fermented product obtained by filtering a fermentation strain from the culture medium, a fermented product obtained by sterilizing a fermentation strain from the culture medium and filtering it, a dilution solution obtained by diluting the fermentation product, and a dried product obtained by drying the fermentation product. It may contain all of the materials. In the present specification, the term fermented extract may be used interchangeably with the fermented soybean extract.
상기 추출은 상기 균주로 발효된 약콩을 물, C1 내지 C4 저급알코올 또는 이들의 혼합물로 추출한 것일 수 있다. 예를 들어, 상기 약콩의 추출에 사용되는 저급 알코올은 에탄올 또는 메탄올인 것일 수 있다. 추출시 약콩을 세절한 후 물, 알코올 또는 이의 혼합물을 약콩 무게의 2배 내지 20배를 첨가하여 추출하는 것일 수 있다. 예를 들어, 3배 내지 10배를 첨가하여 추출하는 것일 수 있다. 추출온도는 30℃ 내지 100℃, 60℃ 내지 100℃. 30℃ 내지 90℃, 30℃ 내지 80℃, 60℃ 내지 90℃, 또는 60℃ 내지 80℃인 것일 수 있다. 추출시간은 1시간 내지 10시간, 2시간 내지 8시간, 2 내지 5시간, 3 내지 7시간 또는 4 내지 6시간인 것일 수 있다. 추출방법은 냉침, 초음파 추출 또는 환류 냉각 추출방법이 모두 이용 가능하다. 추출 횟수는 1회 내지 5회, 2회 내지 4회, 3 내지 5회 반복 추출하는 것일 수 있다.The extraction may be obtained by extracting the yak bean fermented with the strain with water, C1 to C4 lower alcohol, or a mixture thereof. For example, the lower alcohol used in the extraction of the yak bean may be ethanol or methanol. During extraction, after slicing the yak bean, water, alcohol, or a mixture thereof may be extracted by adding 2 to 20 times the weight of the yak bean. For example, it may be extracted by adding 3 to 10 times. Extraction temperature is 30 ℃ to 100 ℃, 60 ℃ to 100 ℃. It may be 30 ℃ to 90 ℃, 30 ℃ to 80 ℃, 60 ℃ to 90 ℃, or 60 ℃ to 80 ℃. The extraction time may be 1 hour to 10 hours, 2 hours to 8 hours, 2 to 5 hours, 3 to 7 hours, or 4 to 6 hours. As for the extraction method, cold sedimentation, ultrasonic extraction, or reflux cooling extraction method can all be used. The number of extractions may be 1 to 5 times, 2 to 4 times, and 3 to 5 times of repeated extraction.
상기 약콩 발효 추출물은 60 내지 80% 에탄올로 추출한 것일 수 있다. 일 구체예에 있어서, 상기 약콩 발효물의 추출 조건에 따라 피부 주름 개선 효과 및 항산화능을 비교한 결과, 열수 발효 추출물, 및 5% 내지 70% 에탄올로 추출된 발효 추출물 모두 우수한 효과를 나타내었고, 특히, 70% 에탄올로 추출된 발효 추출물이 가장 높은 주름 개선 효과 및 항산화능을 나타냄을 확인하였다.The fermented soybean extract may be extracted with 60 to 80% ethanol. In one embodiment, as a result of comparing the skin wrinkle improvement effect and antioxidant ability according to the extraction conditions of the fermented soybean fermented product, both the hot water fermented extract and the fermented extract extracted with 5% to 70% ethanol exhibited excellent effects, especially , It was confirmed that the fermented extract extracted with 70% ethanol showed the highest anti-wrinkle effect and antioxidant activity.
상기 화장료 조성물은 피부 개선 효과를 나타낼 수 있다. 본 명세서 내 용어, "피부 개선"은 피부 상태를 개선시키는 것을 총칭하는 의미로 사용될 수 있으며, 구체적으로 상기 피부 개선은 피부 주름 개선, 피부 항산화능, 또는 피부 장벽 강화일 수 있으나, 이에 제한되지 않는다. 상기 용어, "주름"은 피부가 쇠하여 생긴 잔줄을 의미하는데, 유전자에 의한 원인, 피부 진피에 존재하는 콜라겐의 감소, 외부 환경 등에 의해 유발될 수 있다. 상기 용어, "주름 개선"이란 피부에 주름이 생기는 것을 억제 또는 저해하거나 이미 생성된 주름을 완화시키는 것을 의미한다. 피부 탄력 개선 또는 증가에 의해 피부 주름이 완화시키는 것을 포함하며, 예를 들어, 모공면적을 감소시킴으로써 피부 주름을 개선시키는 것을 포함할 수 있다. 상기 용어 "항산화능"이란 좁은 범위로는 체내에서 생성되는 자유라디칼, 상기 자유라디칼로부터 생성되는 과산화수소 또는 과산화물, 상기 과산화수소로부터 생성되는 하이드록시 라디칼의 생성 또는 반응을 억제, 감소 또는 제어하는 작용을 의미하고, 넓은 범위로는 자연계에서 발생하는 산화반응의 생성을 억제, 감소 또는 제어하는 작용을 의미할 수 있다. 상기 용어 "피부 장벽 강화"란 피부 가장 바깥쪽에 위치하여 수분과 영양 손실을 막아주는 피부 장벽의 기능이 증진되는 모든 작용을 의미할 수 있다. 일 구체예에 있어서, 상기 약콩 발효물은 발효되지 않은 약콩 추출물과 비교하여 유의적인 피부 개선 효과 및 항산화 효과를 나타냄을 확인하였다.The cosmetic composition may exhibit a skin improvement effect. In the present specification, the term "skin improvement" may be used in a generic sense to improve skin condition, and specifically, the skin improvement may be skin wrinkle improvement, skin antioxidant activity, or skin barrier strengthening, but is not limited thereto. . The term "wrinkle" refers to fine lines caused by deterioration of the skin, and may be caused by genes, a decrease in collagen present in the skin dermis, an external environment, and the like. The term "wrinkle improvement" refers to inhibiting or inhibiting the occurrence of wrinkles on the skin or relieving wrinkles that have already been created. It includes alleviating skin wrinkles by improving or increasing skin elasticity, and may include, for example, improving skin wrinkles by reducing the pore area. The term "antioxidant activity" refers to an action of inhibiting, reducing or controlling the generation or reaction of free radicals generated in the body, hydrogen peroxide or peroxide generated from the free radicals, and hydroxy radicals generated from the hydrogen peroxide in a narrow range. And, in a broad range, it may mean an action of inhibiting, reducing or controlling the generation of oxidation reactions occurring in nature. The term "strengthening the skin barrier" may refer to any action that enhances the function of the skin barrier, which is located on the outermost side of the skin and prevents loss of moisture and nutrition. In one embodiment, it was confirmed that the fermented yak bean exhibited significant skin improvement effect and antioxidant effect compared to the non-fermented yak bean extract.
상기 화장료 조성물은 전체 조성물 중량에 대하여 1 내지 30㎍/mL의 농도로 약콩 발효물을 포함할 수 있다. 예를 들어, 상기 약콩 발효물은 1 내지 30 ㎍/mL, 1 내지 25 ㎍/mL, 1 내지 20 ㎍/mL, 3 내지 30 ㎍/mL, 5 내지 25 ㎍/mL, 5 내지 20 ㎍/mL, 또는 10 내지 20 ㎍/mL의 농도로 포함된 것일 수 있다. 이때, 약콩 발효물이 상기 중량부 미만인 경우, 뚜렷한 피부 개선 효과를 기대하기 어렵고, 약콩 발효물이 상기 중량부를 초과하는 경우, 함유량 증가에 따른 뚜렷한 효과의 증가가 나타나기 어렵고, 제형상 및 제품의 안정성에 다소 문제를 일으킬 수 있으며, 신체 내 독성 등의 문제점이 있을 수 있다.The cosmetic composition may include fermented soybeans at a concentration of 1 to 30 μg/mL based on the total weight of the composition. For example, the fermented soybean product is 1 to 30 μg/mL, 1 to 25 μg/mL, 1 to 20 μg/mL, 3 to 30 μg/mL, 5 to 25 μg/mL, 5 to 20 μg/mL Or, it may be included in a concentration of 10 to 20 ㎍ / mL. At this time, if the fermented soybean product is less than the above parts by weight, it is difficult to expect a clear skin improvement effect, and if the fermented soybean product exceeds the above parts by weight, it is difficult to increase the apparent effect due to the increase in content, and the formulation and stability of the product It may cause some problems, and there may be problems such as toxicity in the body.
상기 화장료 조성물은 상기 유효성분 이외에 통상적으로 허용되는 성분들을 제한없이 포함할 수 있으며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함할 수 있다. 필요에 따라 계면활성제, 산화방지제, 방부제, pH 조절제, 보습제, 윤활제 등의 성분을 더 첨가할 수 있다. 또한, 상기 화장료 조성물은 피부에 필수 영양소를 보조적으로 제공할 수 있는 물질을 추가로 포함하는데, 바람직하게는 천연향, 화장품향, 또는 식물추출물이 포함되지만 이들에 국한되지 않는 보조제를 함유할 수 있다. The cosmetic composition may include, without limitation, ingredients that are generally allowed in addition to the active ingredient, and may include conventional adjuvants such as antioxidants, stabilizers, solubilizers, vitamins, pigments and fragrances, and a carrier. If necessary, ingredients such as surfactants, antioxidants, preservatives, pH adjusters, moisturizers, and lubricants may be further added. In addition, the cosmetic composition additionally includes a substance that can supplementaryly provide essential nutrients to the skin, and preferably includes a natural scent, cosmetics scent, or plant extracts, but may contain adjuvants that are not limited thereto. .
상기 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들면, 용액, 유탁액, 현탁액, 페이스트, 크림, 로션, 겔, 파우더, 스프레이, 계면활성제-함유 클린징, 오일, 비누, 액체 세정료, 입욕제, 파운데이션, 메이크업베이스, 에센스, 화장수, 폼, 팩, 유연수, 선 스크린 크림, 선오일 등의 제형으로 제조될 수 있고, 바람직하게는 피부외용연고, 유연화장수, 영양화장수, 영양크림, 마사지크림, 에센스, 팩, 에멀젼 또는 오일젤의 제형으로 제조될 수 있는데, 이때, 사용되는 담체는 화장품의 제형에 따라 선택적으로 사용될 수 있다. 예를 들어, 연고, 페이스트, 크림 또는 젤 형태의 화장품을 제조할 경우에는, 담체 성분으로서 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크, 산화 아연 등을 단독으로 또는 조합하여 사용할 수 있고; 파우더 또는 스프레이 형태의 화장품을 제조할 경우에는, 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록사이드, 칼슘 실케이트, 폴리아미드 파우더, 클로로플루오로하드로카본, 프로판/부탄, 디메틸 에테르 등을 단독으로 또는 조합하여 사용할 수 있으며; 용액 또는 유탁액 형태의 화장품을 제조할 경우에는, 담체 성분으로서 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 목화씨 오일, 땅콩 오일, 옥수수 배종 오일, 올리브 오일, 피마자 오일, 참깨 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르 등을 단독으로 또는 조합하여 사용할 수 있고; 현탁액 형태의 화장품을 제조할 경우에는, 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르, 폴리옥시에틸렌 소르비탄 에스테르, 미소결정성 셀룰로오스, 알루미늄 메타하이드록시드, 벤토나이트, 아가, 트라칸트 등을 단독으로 또는 조합하여 사용할 수 있으며; 화장비누 형태의 화장품을 제조할 경우에는, 담체 성분으로서 지방산의 알칼리 금속 염, 지방산 헤미에스테르 염, 지방산 단백질 히드롤리제이트, 이세티오네이트, 라놀린 유도체, 지방족 알코올, 식물성 유, 글리세롤, 당 등을 단독으로 또는 조합하여 사용할 수 있다.The cosmetic composition may be prepared in any formulation commonly manufactured in the art, for example, solution, emulsion, suspension, paste, cream, lotion, gel, powder, spray, surfactant-containing cleansing, oil , Soap, liquid detergent, bath agent, foundation, makeup base, essence, lotion, foam, pack, softening water, sunscreen cream, sun oil, etc. formulations, preferably skin ointment, softening lotion, nutrition It can be prepared as a formulation of a lotion, nutrition cream, massage cream, essence, pack, emulsion or oil gel, in which case, the carrier used may be selectively used depending on the formulation of the cosmetics. For example, in the case of manufacturing ointments, pastes, creams, or gels, wax, paraffin, starch, tracant, cellulose derivatives, polyethylene glycol, silicone, bentonite, silica, talc, zinc oxide, etc. are used as carrier components. Can be used alone or in combination; In the case of manufacturing a cosmetic product in the form of powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder, chlorofluorohardcarbon, propane/butane, dimethyl ether, etc. are used as carrier components. Can be used either individually or in combination; When manufacturing cosmetics in the form of a solution or emulsion, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butyl glycol oil, cottonseed oil, peanuts as carrier components Oil, corn seed oil, olive oil, castor oil, sesame oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan, etc. may be used alone or in combination; When manufacturing cosmetics in the form of a suspension, water, ethanol or propylene glycol, ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester, polyoxyethylene sorbitan ester, microcrystalline cellulose, aluminum metahydroxide as carrier components , Bentonite, agar, tracanth, and the like may be used alone or in combination; When manufacturing cosmetics in the form of cosmetic soap, alkali metal salts of fatty acids, fatty acid hemiester salts, fatty acid protein hydrolysates, isethionate, lanolin derivatives, aliphatic alcohols, vegetable oils, glycerol, sugars, etc. are used as carrier components. They can be used alone or in combination.
다른 양상은 약콩에 비피도박테리움 애니멀리스 서브스페시스 락티스(Bifidobacterium animalis subsp. Lactis) LDTM 8102 (KCTC13392BP) 균주를 접종하여 발효시킨, 약콩 발효물을 유효성분으로 함유하는 피부 개선용 식품 조성물을 제공한다. 상기 조성물의 구체적인 내용은 전술한 바와 같다. Another aspect is a food composition for skin improvement containing fermented soybeans as an active ingredient, fermented by inoculating Yak bean with Bifidobacterium animalis subsp . Lactis LDTM 8102 (KCTC13392BP) strain. to provide. Details of the composition are as described above.
일 구체예에 따른 피부 개선용 식품 조성물에 있어서, 상기 약콩 발효물을 식품 조성물의 첨가물로 사용하는 경우 이를 그대로 첨가하거나 다른 식품 또는 식품성분과 함께 사용할 수 있고, 통상적인 방법에 따라 적절하게 사용할 수 있다. 유효 성분의 혼합양은 예방, 건강 또는 치료 등의 각 사용 목적에 따라 적합하게 결정할 수 있다.In the food composition for skin improvement according to an embodiment, when the fermented soybean is used as an additive to the food composition, it may be added as it is or may be used with other foods or food ingredients, and may be appropriately used according to a conventional method. have. The mixing amount of the active ingredient can be appropriately determined according to each purpose of use, such as prevention, health or treatment.
식품 조성물의 제형은 산제, 과립제, 환, 정제, 캡슐제의 형태뿐만 아니라 일반 식품 또는 음료의 형태 어느 것이나 가능하다.The formulation of the food composition may be in the form of powders, granules, pills, tablets, capsules, as well as general foods or beverages.
상기 식품의 종류에는 특별히 제한은 없고, 상기 물질을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸콜렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 식품을 모두 포함할 수 있다.The type of food is not particularly limited, and examples of foods to which the above substances can be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, and dairy products including ice cream. , Various soups, beverages, teas, drinks, alcoholic beverages and vitamin complexes, and may include all foods in the usual sense.
일반적으로, 식품 또는 음료의 제조시에 상기 약콩 발효물은 원료 100 중량부에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양으로 첨가할 수 있다. 그러나, 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있으며, 또한 본 발명은 천연물로부터의 분획물을 이용하는 점에서 안전성 면에서 문제가 없으므로 상기 범위 이상의 양으로도 사용할 수 있다.In general, when preparing food or beverage, the fermented soybean may be added in an amount of 15 parts by weight or less, preferably 10 parts by weight or less based on 100 parts by weight of raw materials. However, in the case of long-term intake for the purpose of health and hygiene or for the purpose of health control, the amount may be less than the above range, and the present invention has no problem in terms of safety in terms of using fractions from natural products. It can also be used in the above amount.
일 구체예에 따른 식품 조성물 중 음료는 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로 함유할 수 있다. 상술한 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜일 수 있다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명에 따른 음료 100 mL당 약 0.01 ~ 0.04 g, 바람직하게는 약 0.02 ~ 0.03 g일 수 있다.In the food composition according to an embodiment, the beverage may contain various flavoring agents or natural carbohydrates as an additional component, like a conventional beverage. The natural carbohydrates described above may be monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, and polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the sweetener, natural sweeteners such as taumatin and stevia extract, and synthetic sweeteners such as saccharin and aspartame can be used. The ratio of the natural carbohydrate may be about 0.01 to 0.04 g, preferably about 0.02 to 0.03 g per 100 mL of the beverage according to the present invention.
상기 외에 일 구체예에 따른 피부 개선용 식품 조성물은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제를 함유할 수 있다. 그 밖에 본 발명의 피부 개선용 조성물은 천연 과일쥬스, 과일쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 혼합하여 사용할 수 있다. 이러한 첨가제의 비율은 제한되지 않으나 상기 식품 조성물 100 중량부 대비 0.01 ~ 0.1 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the above, the food composition for improving skin according to an embodiment includes various nutrients, vitamins, electrolytes, flavoring agents, coloring agents, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, It may contain preservatives, glycerin, alcohols, carbonates used in carbonated beverages. In addition, the composition for improving skin of the present invention may contain pulp for the production of natural fruit juice, fruit juice beverage and vegetable beverage. These ingredients may be used independently or in combination. The ratio of these additives is not limited, but it is generally selected from 0.01 to 0.1 parts by weight based on 100 parts by weight of the food composition.
또 다른 양상은 약콩에 비피도박테리움 애니멀리스 서브스페시스 락티스(Bifidobacterium animalis subsp. Lactis) LDTM 8102 (KCTC13392BP) 균주를 접종하여 발효시킨, 약콩 발효물을 유효성분으로 함유하는 피부 개선용 사료 조성물을 제공한다. 상기 조성물의 구체적인 내용은 전술한 바와 같다.Another aspect is a feed composition for skin improvement containing fermented soybean fermented product by inoculating and fermenting Yak bean with Bifidobacterium animalis subsp . Lactis LDTM 8102 (KCTC13392BP) strain as an active ingredient Provides. Details of the composition are as described above.
상기 사료 조성물은 투여를 위해서 약콩 발효물 이외에 추가로 구연산, 푸마르산, 아디프산, 젖산 등의 유기산; 인산칼륨, 인산나트륨, 중합 인산염 등의 인산염; 폴리페놀, 카테친, 토코페롤, 비타민 C, 녹차 추출물, 키토산, 탄니산 등의 천연 항산화제 중 1종 이상을 혼합하여 사용할 수 있다. 또한 희석제, 분산제, 계면활성제, 결합제 또는 윤활제를 부가적으로 첨가하여 수용액, 현탁액, 유탁액 등과 같은 주사용 제형, 캡슐, 과립 또는 정제로 제제화할 수 있다.The feed composition is an organic acid such as citric acid, fumaric acid, adipic acid, lactic acid in addition to the fermented soybean for administration; Phosphates such as potassium phosphate, sodium phosphate, and polymerized phosphate; One or more of natural antioxidants such as polyphenol, catechin, tocopherol, vitamin C, green tea extract, chitosan, and tannic acid may be mixed and used. In addition, a diluent, a dispersant, a surfactant, a binder, or a lubricant may be additionally added to form an injectable formulation such as an aqueous solution, suspension, emulsion, etc., capsules, granules or tablets.
또한, 상기 사료 조성물은 보조성분으로 아미노산, 무기염류, 비타민, 항산화제, 항진균제, 항균제 등과 같은 각종 보조제 및 분쇄 또는 파쇄된 밀, 보리, 옥수수 등의 식물성 단백질 사료, 혈분, 육분, 생선분 등의 동물성 단백질 사료, 동물성 지방 및 식물성 지방 같은 주성분 이외에도 영양 보충제, 성장 촉진제, 소화 흡수 촉진제, 질병 예방제와 함께 사용될 수 있다.In addition, the feed composition is an auxiliary ingredient, various auxiliary agents such as amino acids, inorganic salts, vitamins, antioxidants, antifungal agents, antibacterial agents, and vegetable proteins such as crushed or crushed wheat, barley, corn feed, blood meal, meat meal, fish meal, etc. In addition to the main ingredients such as animal protein and feed, animal fat and vegetable fat, it can be used with nutritional supplements, growth promoters, digestive and absorption promoters, and disease prevention agents.
상기 사료 조성물을 사료 첨가물로 사용할 경우, 상기 사료 조성물을 그대로 첨가하거나 다른 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 사료 조성물의 투여 형태는 비독성 제약상 허용 가능한 담체와 조합하여 즉시 방출 또는 서방성 제형으로 제조할 수 있다. 이러한 식용 담체는 옥수수 전분, 락토스, 수크로스, 프로필렌 글리콜일 수 있다. 고체형 담체의 경우에는 정제, 산제, 토로키제 등의 투여 형태일 수 있으며 액체형 담체의 경우에는 시럽제, 액체 현탁액제, 에멀젼제, 용액제 등의 투여 형태일 수 있다. 또한, 투여제는 보존제, 윤화제, 용액 촉진제, 안정화제를 함유할 수 있으며 다른 염증 질환 개선제 및 바이러스 예방상 유용한 물질을 함유할 수도 있다.When the feed composition is used as a feed additive, the feed composition may be added as it is or used with other ingredients, and may be appropriately used according to a conventional method. The dosage form of the feed composition can be prepared as an immediate release or sustained release formulation in combination with a non-toxic pharmaceutically acceptable carrier. Such edible carriers may be corn starch, lactose, sucrose, propylene glycol. In the case of a solid carrier, it may be a dosage form such as a tablet, a powder, or a toroki agent, and in the case of a liquid carrier, a dosage form such as a syrup, a liquid suspension, an emulsion, or a solution may be used. In addition, the administration agent may contain a preservative, a lubricant, a solution accelerator, a stabilizer, and other inflammatory disease ameliorating agents and substances useful for virus prevention.
상기 사료 조성물은 포유류, 가금류, 어류 및 갑각류를 포함하는 다수의 동물 식이 즉, 사료에 적용할 수 있다. 상업용으로 중요한 돼지, 소, 염소 등의 포유류, 코끼리, 낙타 등의 동물원 동물, 개, 고양이 등의 가축에게 사용할 수 있다. 상업적으로 중요한 가금류에는 닭, 오리, 거위 등이 포함되며, 송어와 새우와 같은 상업적으로 사육되는 어류 및 갑각류를 포함 할 수 있다.The feed composition can be applied to a number of animal diets, that is, feed, including mammals, poultry, fish and crustaceans. It can be used for commercially important mammals such as pigs, cows, goats, zoo animals such as elephants and camels, and livestock such as dogs and cats. Commercially important poultry includes chickens, ducks and geese, and may include commercially raised fish and crustaceans such as trout and shrimp.
또 다른 양상은 약콩에 비피도박테리움 애니멀리스 서브스페시스 락티스(Bifidobacterium animalis subsp. Lactis) LDTM 8102 (KCTC13392BP) 균주를 접종하여 발효시킨, 약콩 발효물을 유효성분으로 함유하는 피부 개선용 약학 조성물을 제공한다. 상기 조성물의 구체적인 내용은 전술한 바와 같다.Another aspect is a pharmaceutical composition for skin improvement containing a fermented soybean fermented product by inoculating and fermenting the Bifidobacterium animalis subsp . Lactis LDTM 8102 (KCTC13392BP) strain in Yak Soybean as an active ingredient Provides. Details of the composition are as described above.
본 명세서 내 용어, "약학 조성물"이란, 질병의 예방 또는 치료를 목적으로 제조된 것을 의미하며, 각각의 통상의 방법에 따라 다양한 형태로 제형화하여 사용될 수 있다. 예컨대, 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽 등의 제형으로 제형화할 수 있고, 외용제, 좌제 및 멸균 주사용액의 형태로 제형화하여 사용될 수 있다. 구체적으로, 점안투여하기 적합한 형태, 예를 들어, 점안제, 크림제, 연고제, 겔제 또는 로션제로 제형화하여 사용될 수 있다.As used herein, the term "pharmaceutical composition" refers to a product prepared for the purpose of preventing or treating a disease, and may be formulated and used in various forms according to respective conventional methods. For example, it can be formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, and the like, and can be formulated in the form of external preparations, suppositories, and sterile injectable solutions. Specifically, it may be formulated and used in a form suitable for eye drop administration, for example, eye drops, creams, ointments, gels or lotions.
상기 약학 조성물은, 약학적 조성물의 제조에 통상적으로 사용하는 적절한 담체, 부형제 또는 희석제를 추가로 포함하는 창상 예방 또는 치료용 약학 조성물의 형태로 제조될 수 있는데, 상기 담체는 비자연적 담체(non-naturally occuring carrier)를 포함할 수 있다. The pharmaceutical composition may be prepared in the form of a pharmaceutical composition for preventing or treating wounds, further comprising an appropriate carrier, excipient, or diluent commonly used in the preparation of pharmaceutical compositions, wherein the carrier is a non-natural carrier. naturally occuring carrier).
상기 약학 조성물에 포함될 수 있는 담체, 부형제 및 희석제로는 락토즈, 덱스트로즈, 수크로스, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로즈, 메틸 셀룰로즈, 미정질 셀룰로스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유를 들 수 있다.Carriers, excipients and diluents that may be included in the pharmaceutical composition include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, gum acacia, alginate, gelatin, calcium phosphate, calcium silicate, cellulose , Methyl cellulose, microcrystalline cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate, and mineral oils.
제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. 경구 투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 상기 상엽 추출물과 이의 분획물들에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘카보네이트(calcium carbonate), 수크로스(sucrose) 또는 락토오스(lactose), 젤라틴 등을 섞어 조제된다. 또한 단순한 부형제 이외에 마그네슘 스티레이트, 탈크 같은 윤활제들도 사용된다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는 데 흔히 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조 제제, 좌제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜(propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween) 61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다.In the case of formulation, it is prepared using diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrants, and surfactants that are usually used. Solid preparations for oral administration include tablets, pills, powders, granules, capsules, and the like, and such solid preparations include at least one excipient, such as starch, calcium carbonate, in the upper leaf extract and its fractions. , Sucrose (sucrose) or lactose (lactose), gelatin, etc. are mixed and prepared. In addition to simple excipients, lubricants such as magnesium stearate and talc are also used. Liquid preparations for oral use include water and liquid paraffin, which are simple diluents commonly used for suspensions, liquid solutions, emulsions, syrups, etc., and various excipients such as wetting agents, sweetening agents, fragrances, and preservatives. have. Preparations for parenteral administration include sterile aqueous solutions, non-aqueous solutions, suspensions, emulsions, lyophilized preparations, and suppositories. As the non-aqueous solvent and suspension, propylene glycol, polyethylene glycol, vegetable oil such as olive oil, and injectable ester such as ethyl oleate may be used. As a base for suppositories, witepsol, macrogol, tween 61, cacao butter, laurin, glycerogelatin, and the like may be used.
일 양상에 따른 조성물은 피부 상태 개선에 이용될 수 있다. 구체적으로, 외인성 피부 노화의 주된 원인인 광노화에 의한 피부 장벽을 구성하는 콜라겐의 분해를 효과적으로 억제하여, 피부 주름 개선에 현저한 효과를 나타낼 수 있다. The composition according to an aspect may be used to improve skin conditions. Specifically, by effectively suppressing the decomposition of collagen constituting the skin barrier due to photoaging, which is the main cause of exogenous skin aging, it can exhibit a remarkable effect on skin wrinkle improvement.
다른 양상에 따른 조성물은 항산화 조성물에 이용될 수 있다. 구체적으로, 약콩 발효물은 발효되지 않은 약콩 추출물에 비해 현저히 높은 수준의 항산화능을 나타낼 수 있다.The composition according to another aspect may be used in an antioxidant composition. Specifically, the fermented yak bean may exhibit a significantly higher level of antioxidant activity compared to the non-fermented yak bean extract.
도 1은 비피도박테리움 애니멀리스 서브스페시스 락티스(Bifidobacterium animalis subsp. Lactis.) LDTM 8102(수탁번호: KCTC13392BP)를 이용하여 약콩 발효물을 제조하는 공정을 대략적으로 나타낸 도면이다.
도 2는 자외선에 노출된 피부 각질세포에서 발효하지 않은 약콩 추출물 (UFY: Unfermented Yak-kong), 실시예 1의 약콩 발효물 (EFY: 70% EtOH extract of fermented Yak-kong with Bifidobacterium animalis subsp. Lactis LDTM 8102), 및 비교예 1의 약콩 발효물 (Ref.: 70% EtOH extract of fermented Yak-kong with Bifidobacterium animalis subsp. Lactis KCTC 5854)에 의한 콜라겐분해효소의 저감 효능을 비교한 결과를 나타낸 도면이다.
도 3은 자외선에 노출된 피부 각질세포에서 비피도박테리움 애니멀리스 서브스페시스 락티스 LDTM 8102로 발효된 약콩 발효물의 열수 추출물 (H2O), 5%, 10%, 30%, 50%, 및 70% 주정 추출물 (5%, 10%, 30%, 50%, 70% EtOH)에 의한 콜라겐분해효소의 저감 효능을 비교한 결과를 나타낸 도면이다.
도 4는 발효되지 않은 약콩 추출물 (UFY), 약콩 발효물의 열수 추출물 (WFY), 약콩 발효물의 70% 주정 추출물 (EFY)의 항산화 활성을 비교한 그래프이다.
도 5는 발효되지 않은 약콩 추출물 (UFY), 약콩 발효물의 열수 추출물 (WFY), 약콩 발효물의 70% 주정 추출물 (EFY)의 총 폴리페놀 함량을 비교한 결과를 그래프이다.
도 6은 비피도박테리움 애니멀리스 서브스페시스 락티스 LDTM 8102로 발효된 약콩 발효물의 70% 주정 추출물의 처리 농도에 따른 MMP-1의 저감 효과를 비교한 결과를 나타낸 도면이다.1 is a view schematically showing a process for preparing a fermented soybean product using Bifidobacterium animalis subsp. Lactis. LDTM 8102 (Accession No. KCTC13392BP).
FIG. 2 is a non-fermented yak bean extract (UFY: Unfermented Yak-kong) from skin keratinocytes exposed to UV rays, and a yak bean fermented product of Example 1 (EFY: 70% EtOH extract of fermented Yak-kong with Bifidobacterium animalis subsp.Lactis) LDTM 8102 ), and the fermented Yak-kong of Comparative Example 1 (Ref.: 70% EtOH extract of fermented Yak-kong with Bifidobacterium animalis subsp. Lactis KCTC 5854 ) is a view showing the result of comparing the reduction efficacy of collagenase .
Figure 3 is a hot water extract of fermented soybean fermented with Bifidobacterium animalis subsposis lactis LDTM 8102 in skin keratinocytes exposed to ultraviolet light (H 2 O), 5%, 10%, 30%, 50%, And 70% alcohol extract (5%, 10%, 30%, 50%, 70% EtOH) is a view showing the result of comparing the reduction efficacy of collagenase.
4 is a graph comparing the antioxidant activity of non-fermented yak bean extract (UFY), hot water extract of yak bean fermented product (WFY), and 70% alcohol extract (EFY) of yak bean fermented product.
5 is a graph showing the results of comparing the total polyphenol content of the non-fermented yak bean extract (UFY), the hot water extract of yak bean fermentation (WFY), and the 70% alcohol extract (EFY) of yak bean fermentation product.
6 is a view showing the result of comparing the reduction effect of MMP-1 according to the treatment concentration of the 70% alcohol extract of fermented Yak bean fermented with Bifidobacterium animalis subsposis lactis LDTM 8102.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나 하기의 실시예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 하기 실시예에 의해 본 발명의 내용이 한정되는 것은 아니다.Hereinafter, a preferred embodiment is presented to aid the understanding of the present invention. However, the following examples are provided for easier understanding of the present invention, and the contents of the present invention are not limited by the following examples.
[실시예][Example]
실시예 1. 약콩 발효물의 제조Example 1. Preparation of fermented soybeans
한국인 유아의 분변에서 분리한 비피도박테리움 애니멀리스 서브스페시스 락티스(Bifidobacterium animalis subsp. Lactis.) LDTM 8102(수탁번호: KCTC13392BP)를 이용하여 약콩 발효물을 제조하였다. 구체적으로, 글리세롤과 혼합하여 -80℃에서 냉동 보관 중인 비티도박테리움 애니멀리스 서브스페시스 락티스(Bifidobacterium animalis subsp. Lactis.) LDTM 8102(수탁번호: KCTC13392BP) 보존액을 MRSC 배지에 접종하여 37℃, 혐기 조건에서 20 내지 24시간 동안 정치하는 전 배양 과정을 수행하였다. 이후, 50 g/L의 약콩 분말에 전 배양 과정을 수행하여 활성을 높인 상기 균주 배양액을 접종한 후, 37℃로 유지된 혐기 조건에서 진탕배양 하였다. 발효 과정에서 수집된 시료들을 열처리 공정을 거쳐 동결건조 하였고, 상기 시료를 0.5 g 당 10㎖의 비율로 0, 5, 10, 30, 50, 및 70% 발효주정(식물성 알코올)을 각각 첨가하여 75℃에서 2시간 동안 중탕한 후, 각각 추출하였다. 이후, 상온에서 1시간 정도 방치하여 식힌 뒤, 5000 rpm으로 10분 간 원심분리하여 상층액을 분리하였다. 분리된 상층액을 0.2 ㎛ syrine filter를 이용하여 여과하고, 40℃ 감압농축기에서 주정을 모두 제거한 후 동결건조하여 분말화 하였다. 이후, 상기 동결건조된 분말을 50% DMSO에 용해하여 약콩 발효 물로 사용하였다. 비피도박테리움 애니멀리스 서브스페시스 락티스(Bifidobacterium animalis subsp. Lactis.) LDTM 8102(수탁번호: KCTC13392BP)를 이용하여 약콩 발효물을 제조하는 전반적인 공정을 도 1에 나타내었다.A fermented soybean product was prepared using Bifidobacterium animalis subsp. Lactis. LDTM 8102 (accession number: KCTC13392BP) isolated from the feces of Korean infants. Specifically, Bifidobacterium animalis subsp. Lactis ( Bifidobacterium animalis subsp. Lactis.) LDTM 8102 (accession number: KCTC13392BP) preservative solution mixed with glycerol and stored frozen at -80°C was inoculated in MRSC medium to , The entire cultivation process was performed by standing for 20 to 24 hours in anaerobic conditions. Thereafter, 50 g/L of yak bean powder was inoculated with the strain culture solution having increased activity by performing the entire culturing process, and then cultured with shaking under anaerobic conditions maintained at 37°C. Samples collected in the fermentation process were lyophilized through a heat treatment process, and 0, 5, 10, 30, 50, and 70% fermented alcohol (vegetable alcohol) were added to the sample at a rate of 10 ml per 0.5 g. After bathing for 2 hours at °C, each was extracted. Thereafter, it was allowed to stand at room temperature for about 1 hour to cool, and then centrifuged at 5000 rpm for 10 minutes to separate the supernatant. The separated supernatant was filtered using a 0.2 µm syrine filter, and all alcohol was removed in a vacuum concentrator at 40°C, and then lyophilized to powder. Thereafter, the lyophilized powder was dissolved in 50% DMSO and used as fermented soybeans. Fig. 1 shows an overall process for preparing a fermented soybean product using Bifidobacterium animalis subsp. Lactis. LDTM 8102 (accession number: KCTC13392BP).
비교예 1. 약콩 발효물의 제조Comparative Example 1. Preparation of fermented soybeans
비피도박테리움 애니멀리스 서브스페시스(Bifidobacterium animalis subsp. Lactis) KCTC5854 유산균 (Ref.)을 이용하여 약콩을 발효하였다는 점을 제외하고는, 상기 실시예 1과 동일한 방법으로 약콩 발효물을 제조하였다.Except that yak beans were fermented using Bifidobacterium animalis subsp.Lactis KCTC5854 lactic acid bacteria (Ref.), a fermented soybean product was prepared in the same manner as in Example 1 .
[실험예][Experimental Example]
실험예 1. 콜라겐분해효소 저감 효과 확인Experimental Example 1. Confirmation of collagenase reduction effect
상기 실시예 1의 약콩 발효물의 피부 주름 개선 효과를 확인하고, 실시예 1과 다른 유산균을 이용하여 제조된 비교예 1의 약콩 발효물과 그 효과를 비교하기 위하여, 피부 각질세포 (HaCaT, immortalized human keratinocyte cell line)에서 콜라겐 분해 효소를 저감시키는 효과를 확인하였다. 구체적으로, 웨스턴 블랏 분석을 이용하여 콜라겐 분해효소인 MMP-1 (Matrix metalloproteinase-1)의 분비를 측정하였다. HaCaT 세포는 5% CO2 및 37℃ 조건에서 10% (v/v) FBS 및 1% (v/v) 페니실린/스트렙토마이신을 함유하는 DMEM 배지에서 배양하였다. HaCaT 세포를 24시간 동안 배양하고, 배지를 무혈청 (serum-free) DMEM 배지로 교체하였다. 37℃에서 24시간 동안 배양한 후, HaCaT 세포를 무혈청 배지에 80 ㎍/ml 농도로 발효하지 않은 약콩 추출물, 실시예 1의 약콩 발효물, 또는 비교예 1의 약콩 발효물을 처리한 후 1시간 동안 인큐베이션하였다. 25 kJ/m2 세기의 sUV를 조사한 후, 48시간 동안 배양하였다. 배지를 얼음 위에서 수확한 다음 18,620 g에서 10분 동안 원심분리하였다. 용제의 단백질 농도는 제조사가 기술한 바와 같이 단백질 분석 시약 키트를 사용하여 측정하였다. 단백질은 10% SDS-폴리아크릴아마이드 겔을 이용하여 SDS-PAGE에 의해 전기영동으로 분리하고, Immobilon-P PVDE (MERK Millipore, Darmstadt, Germany)에 옮겼다. 5% 스킴 밀크 (skim milk)에서 1시간 동안 블로킹 처리한 후, 4℃에서 하룻밤 동안 1차 항체를 붙였다. 단백질 밴드는 2차 항체 (Life techonologies, Waltham, MA, USA)를 처리한 후, 화학 발광 (chemiluminescence) 검출 키트 (GE healthcare, Little Chalfont, UK)를 이용하여 시각화하였다. 상기 시험은 3회 반복하였다.In order to confirm the effect of improving skin wrinkles of the fermented soybeans of Example 1, and to compare the effects with the fermented soybeans of Comparative Example 1 prepared using other lactic acid bacteria from Example 1, skin keratinocytes (HaCaT, immortalized human keratinocyte cell line). Specifically, the secretion of the collagen-degrading enzyme MMP-1 (Matrix metalloproteinase-1) was measured using Western blot analysis. HaCaT cells were cultured in DMEM medium containing 10% (v/v) FBS and 1% (v/v) penicillin/streptomycin at 5% CO 2 and 37°C. HaCaT cells were cultured for 24 hours, and the medium was replaced with a serum-free DMEM medium. After culturing at 37° C. for 24 hours, HaCaT cells were treated in a serum-free medium at a concentration of 80 µg/ml and not fermented Yak bean extract, Yak bean fermented product of Example 1, or Yak bean fermented product of Comparative Example 1 1 Incubated for hours. After irradiation with sUV of 25 kJ/m 2 intensity, it was cultured for 48 hours. The medium was harvested on ice and then centrifuged at 18,620 g for 10 minutes. The protein concentration of the solvent was measured using a protein assay reagent kit as described by the manufacturer. Protein was separated by electrophoresis by SDS-PAGE using 10% SDS-polyacrylamide gel, and transferred to Immobilon-P PVDE (MERK Millipore, Darmstadt, Germany). After blocking treatment for 1 hour in 5% skim milk, the primary antibody was attached overnight at 4°C. Protein bands were visualized using a chemiluminescence detection kit (GE healthcare, Little Chalfont, UK) after treatment with a secondary antibody (Life techonologies, Waltham, MA, USA). The test was repeated 3 times.
도 2는 자외선에 노출된 피부 각질세포에서 발효하지 않은 약콩 추출물 (UFY: Unfermented Yak-kong), 실시예 1의 약콩 발효물 (EFY: 70% EtOH extract of fermented Yak-kong with Bifidobacterium animalis subsp. Lactis LDTM 8102), 및 비교예 1의 약콩 발효물 (Ref.: 70% EtOH extract of fermented Yak-kong with Bifidobacterium animalis subsp. Lactis KCTC 5854)에 의한 콜라겐분해효소의 저감 효능을 비교한 결과를 나타낸 도면이다.FIG. 2 is a non-fermented yak bean extract (UFY: Unfermented Yak-kong) from skin keratinocytes exposed to UV rays, and a yak bean fermented product of Example 1 (EFY: 70% EtOH extract of fermented Yak-kong with Bifidobacterium animalis subsp.Lactis) LDTM 8102 ), and the fermented Yak-kong of Comparative Example 1 (Ref.: 70% EtOH extract of fermented Yak-kong with Bifidobacterium animalis subsp. Lactis KCTC 5854 ) is a view showing the result of comparing the reduction efficacy of collagenase .
그 결과, 도 2에 나타난 바와 같이, 자외선이 조사되지 않은 대조군에 비해, 자외선이 조사될 경우 콜라겐분해효소의 발현이 증가되어, 이는 프로토콜라겐의 생합성을 억제하여 콜라겐의 함량을 감소시켜 피부의 주름생성을 촉진하고, 색소 침착을 유발하여 피부톤을 칙칙하게 만드는 것임을 확인하였다. 이 경우, 발효되지 않은 약콩 추출물을 처리할 경우, 콜라겐분해효소의 발현을 감소시켜 피부 주름 개선 효과를 나타냄을 확인하였다. 또한, 비피도박테리움 애니멀리스 서브스페시스 락티스 KCTC 5854 균주를 이용하여 발효된 약콩 발효물 (비교예 1)은 발효되지 않은 약콩 추출물과 유사한 수준으로 피부 주름 개선 효과를 나타내었으나, 본 발명의 비피도박테리움 애니멀리스 서브스페시스 락티스 LDTM 8102 균주를 이용하여 발효된 약콩 발효물 (실시예 1)은 발효되지 않은 약콩 추출물 및 비교예 1의 약콩 발효물에 비해 현저히 증가된 피부 주름 개선 효과를 나타냄을 확인할 수 있었다. As a result, as shown in FIG. 2, compared to the control group not irradiated with ultraviolet rays, when ultraviolet rays are irradiated, the expression of collagen-degrading enzyme is increased, which inhibits the biosynthesis of protocol ragen and reduces the content of collagen, thereby reducing the skin's wrinkles. It was confirmed that it promotes production and causes pigmentation to make skin tone dull. In this case, it was confirmed that the treatment of the non-fermented yak bean extract showed an effect of improving skin wrinkles by reducing the expression of collagenase. In addition, the fermented soybean fermented product (Comparative Example 1) fermented using the Bifidobacterium animalis subspasis lactis KCTC 5854 strain exhibited an effect of improving skin wrinkles at a level similar to that of the non-fermented soybean extract. The fermented soybean fermented product (Example 1) fermented using the Bifidobacterium animalis subspecis lactis LDTM 8102 strain significantly increased skin wrinkle improvement compared to the non-fermented soybean extract and the fermented soybean fermented product of Comparative Example 1. It was confirmed that it represents.
즉, 상기 결과로부터 일 양상에 따른 약콩 발효물은 발효되지 않은 약콩 추출물뿐만 아니라, 다른 종류의 유산균을 이용하여 발효된 약콩 발효물에 비해서도 현저히 증가된 피부 주름 개선 효과를 나타냄을 확인할 수 있다.That is, it can be seen from the above results that the fermented Yak-bean according to one aspect exhibits a significantly increased skin wrinkle improvement effect compared to the fermented Yak-bean fermented product fermented using not only the non-fermented Yak bean extract, but also other types of lactic acid bacteria.
실험예 2. 추출 조건에 따른 약콩 발효물의 콜라겐분해효소 저감 효과 비교Experimental Example 2. Comparison of collagenase reduction effect of fermented soybeans according to extraction conditions
추출 조건에 따른 약콩 발효물의 피부 주름 개선 효과를 비교하기 위해, 상기 실험예 1에 기재된 방법과 동일한 방법으로 MMP-1의 저감 효과를 비교하였다. 구체적으로, 약콩 발효물의 열수 추출물 (H2O), 5%, 10%, 30%, 50%, 및 70% 주정 추출물 (5%, 10%, 30%, 50%, 70% EtOH)을 80 ㎍/ml로 처리한 후 MMP-1의 저감 효과를 확인하였다. In order to compare the effect of improving skin wrinkles of fermented soybeans according to the extraction conditions, the reduction effect of MMP-1 was compared in the same manner as described in Experimental Example 1. Specifically, hot water extract of fermented soybean (H 2 O), 5%, 10%, 30%, 50%, and 70% alcohol extract (5%, 10%, 30%, 50%, 70% EtOH) 80 After treatment with μg/ml, the effect of reducing MMP-1 was confirmed.
도 3은 자외선에 노출된 피부 각질세포에서 비피도박테리움 애니멀리스 서브스페시스 락티스 LDTM 8102로 발효된 약콩 발효물의 열수 추출물 (H2O), 5%, 10%, 30%, 50%, 및 70% 주정 추출물 (5%, 10%, 30%, 50%, 70% EtOH)에 의한 콜라겐분해효소의 저감 효능을 비교한 결과를 나타낸 도면이다.Figure 3 is a hot water extract of fermented soybean fermented with Bifidobacterium animalis subsposis lactis LDTM 8102 in skin keratinocytes exposed to ultraviolet light (H 2 O), 5%, 10%, 30%, 50%, And 70% alcohol extract (5%, 10%, 30%, 50%, 70% EtOH) is a view showing the result of comparing the reduction efficacy of collagenase.
그 결과, 도 3에 나타난 바와 같이, 자외선 조사시 비피도박테리움 애니멀리스 서브스페시스 락티스 LDTM 8102로 발효된 약콩 발효물의 열수 추출물, 5%, 10%, 30%, 50%, 및 70% 주정 추출물을 처리할 경우에 모두 우수한 피부 주름 개선 효과를 나타냈으며, 특히 상기 약콩 발효물의 70% 주정 추출물을 처리할 경우에 피부 주름 개선 효과가 가장 뛰어남을 확인하였다. As a result, as shown in FIG. 3, hot water extract of fermented soybean fermented with Bifidobacterium animalis subspecis lactis LDTM 8102 when irradiated with ultraviolet rays, 5%, 10%, 30%, 50%, and 70% When the alcohol extract was treated, both showed excellent skin wrinkle improvement effect, and in particular, it was confirmed that the skin wrinkle improvement effect was most excellent when the 70% alcohol extract of the fermented soybean was treated.
실험예 3. 추출 조건에 따른 약콩 발효물의 항산화능 비교Experimental Example 3. Comparison of antioxidant activity of fermented soybeans according to extraction conditions
추출 조건에 따른 약콩 발효물의 항산화능를 비교하기 위해, 비피도박테리움 애니멀리스 서브스페시스 락티스 LDTM 8102로 발효된 약콩 발효물의 열수 추출물 및 70% 주정 추출물의 항산화 효과 및 총 페놀 함량을 비교하였다. 구체적으로, 상기 약콩 발효물의 추출 조건 (열수 추출 또는 70% 주정 추출)에 따른 항산화능을 측정하기 위해 DPPH 소거 활성을 측정하였다. 은박지로 싼 보틀에 80% 메탄올로 희석하여 0.1 mM DPPH 용액 (7.89 mg DPPH/200 mL 80% MeOH)을 준비하고, 이를 20분 동안 섞어주었다. 표준 항산화 용액 (standard antioxidant solution)으로는 비타민 C 100 mg/mL를 사용하고, 표준 곡선을 그리기 위해 1/2씩 희석하여 준비하였다. 블랭크 (blank, 80% 메탄올), DPPH 용액 및 항산화능을 측정하고자 하는 시료 (발효되지 않은 약콩 추출물 (UFY), 약콩 발효물의 열수 추출물 (WFY), 약콩 발효물의 70% 주정 추출물 (EFY))를 1:1로 반응시켰다. DPPH 용액은 517 nm 파장대에서 흡광도가 1.000±0.020 수준이 되도록 최종 부피는 80% 메탄올을 이용하여 200 uL로 맞추었다. 은박지를 이용하여 빛이 들지 않도록 하고, 23℃에서 30분 동안 진탕(shaking) 처리한다. 30분이 지난 최종 시점에서 517 nm 파장대에서 블랭크 군과 비교하여 감소된 흡광도를 측정하였다.In order to compare the antioxidant activity of fermented soybeans according to the extraction conditions, the antioxidant effect and total phenol content of the hot water extract and 70% alcohol extract of the fermented soybean fermented with Bifidobacterium animalis subsposis lactis LDTM 8102 were compared. Specifically, DPPH scavenging activity was measured in order to measure the antioxidant activity according to the extraction conditions (hot water extraction or 70% alcohol extraction) of the fermented soybean product. A 0.1 mM DPPH solution (7.89 mg DPPH/200
또한, 약콩 발효물의 추출 조건(열수 추출 또는 70% 주정 추출)에 따른 항산화능을 측정하기 위해 총 폴리페놀 함량 (total phenolic content)을 측정하였다. 구체적으로, 96 웰 멀티 플레이트의 각 웰에 80 ㎕ 3차 증류수, 10 ㎕ 상기 시료 및 표준 용액, 10 ㎕ 폴린-시오칼투 페놀 시약 (folin-ciocalteu phenol reagent)을 차례대로 넣어준 후, 6분 동안 진탕해주었다. 반응이 끝난 후, 100 ㎕의 7% Na2CO3 용액을 각 웰에 분주한 후 90분 동안 진탕해주었다. 반응이 진행되면서 용액이 푸른색으로 바뀌게 되고, 이를 750 nm 파장대에서 흡광도를 측정하였다. In addition, the total polyphenol content (total phenolic content) was measured in order to measure the antioxidant activity according to the extraction conditions (hot water extraction or 70% alcohol extraction) of the fermented Yak. Specifically, 80 µl tertiary distilled water, 10 µl of the sample and standard solution, and 10 µl folin-ciocalteu phenol reagent were sequentially added to each well of a 96-well multi-plate, and then for 6 minutes. Gave me a shake. After the reaction was over, 100 µl of a 7% Na 2 CO 3 solution was dispensed into each well and shaken for 90 minutes. As the reaction proceeded, the solution turned blue, and the absorbance was measured at a wavelength of 750 nm.
도 4는 발효되지 않은 약콩 추출물 (UFY), 약콩 발효물의 열수 추출물 (WFY), 약콩 발효물의 70% 주정 추출물 (EFY)의 항산화 활성을 비교한 그래프이다. 4 is a graph comparing the antioxidant activity of non-fermented yak bean extract (UFY), hot water extract of yak bean fermented product (WFY), and 70% alcohol extract (EFY) of yak bean fermented product.
도 5는 발효되지 않은 약콩 추출물 (UFY), 약콩 발효물의 열수 추출물 (WFY), 약콩 발효물의 70% 주정 추출물 (EFY)의 총 폴리페놀 함량을 비교한 그래프이다.5 is a graph comparing the total polyphenol content of non-fermented yak bean extract (UFY), hot water extract of yak bean fermented product (WFY), and 70% alcohol extract (EFY) of yak bean fermented product.
도 4 및 도 5에 나타난 바와 같이, 발효되지 않은 약콩 추출물에 비해 약콩 발효물이 높은 항산화능을 나타내었으며, 특히 약콩 발효물의 70% 주정 추출물이 약콩 발효물의 열수 추출물에 비해서도 높은 항산화능을 나타내고, 총 폴리페놀 함량도 유의적으로 증대됨을 확인하였다.As shown in FIGS. 4 and 5, the fermented Yak bean showed higher antioxidant activity compared to the non-fermented Yak bean extract, and in particular, the 70% alcohol extract of the fermented Yak bean showed higher antioxidant activity compared to the hot water extract of the fermented Yak bean, It was confirmed that the total polyphenol content was also significantly increased.
실험예 4. 약콩 발효물의 처리 농도에 따른 주름 개선 효과 확인Experimental Example 4. Confirmation of wrinkle improvement effect according to treatment concentration of fermented soybeans
상기 실험예 2에서 확인된 바와 같이, 가장 우수한 피부 주름 개선 효과를 나타내는 비피도박테리움 애니멀리스 서브스페시스 락티스 LDTM 8102로 발효된 약콩 발효물의 70% 주정 추출물이 농도 의존적으로 피부 주름 개선 효과를 나타내는지 확인하기 위해, 상기 약콩 발효물의 70% 주정 추출물을 각각 20 ㎍/ml, 40 ㎍/ml, 또는 80 ㎍/ml로 처리한 후, 상기 실험예 1에 기재된 방법과 동일한 방법으로 MMP-1의 저감 효과를 비교하였다.As confirmed in Experimental Example 2, 70% alcohol extract of fermented soybean fermented with Bifidobacterium animalis subspasis lactis LDTM 8102 showing the best skin wrinkle improvement effect in a concentration-dependent manner In order to confirm whether it is indicated, the 70% alcohol extract of the fermented soybean was treated with 20 µg/ml, 40 µg/ml, or 80 µg/ml, respectively, and then MMP-1 in the same method as described in Experimental Example 1 The reduction effect of was compared.
도 6은 비피도박테리움 애니멀리스 서브스페시스 락티스 LDTM 8102로 발효된 약콩 발효물의 70% 주정 추출물의 처리 농도에 따른 MMP-1의 저감 효과를 비교한 결과를 나타낸 도면이다. 6 is a view showing the result of comparing the reduction effect of MMP-1 according to the treatment concentration of the 70% alcohol extract of fermented Yak bean fermented with Bifidobacterium animalis subsposis lactis LDTM 8102.
그 결과, 도 6에 나타난 바와 같이, 비피도박테리움 애니멀리스 서브스페시스 락티스 LDTM 8102로 발효된 약콩 발효물은 농도 의존적으로 MMP-1을 저감시키는 것을 확인하였다. 상기 결과로부터 상기 약콩 발효물, 특히 상기 약콩 발효물의 70% 주정 추출물은 농도 의존적으로 피부 주름 개선 효과를 나타냄을 확인할 수 있다.As a result, as shown in FIG. 6, it was confirmed that the fermented soybean fermented with Bifidobacterium animalless subspecis lactis LDTM 8102 reduced MMP-1 in a concentration-dependent manner. From the above results, it can be seen that the fermented Yak-bean, in particular, the 70% alcohol extract of the fermented Yak-bean, exhibits a concentration-dependent effect of improving skin wrinkles.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200030880A KR102171334B1 (en) | 2020-03-12 | 2020-03-12 | Composition for improving skin condition containing a fermented soybean |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200030880A KR102171334B1 (en) | 2020-03-12 | 2020-03-12 | Composition for improving skin condition containing a fermented soybean |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102171334B1 true KR102171334B1 (en) | 2020-10-29 |
Family
ID=73129507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200030880A KR102171334B1 (en) | 2020-03-12 | 2020-03-12 | Composition for improving skin condition containing a fermented soybean |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102171334B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230037108A (en) * | 2021-09-08 | 2023-03-16 | 코스맥스 주식회사 | Bifidobacterium animalis subsp. lactis strain and its use for improving skin conditions |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130027942A (en) * | 2011-09-08 | 2013-03-18 | (주)지에프씨 | Cosmetic composition comprising fermented extract of ilex paraguayensis |
KR20130096604A (en) * | 2012-02-22 | 2013-08-30 | 아담휴 주식회사 | Making method of facial moisturizer |
KR20180071721A (en) * | 2016-12-20 | 2018-06-28 | 경북대학교 산학협력단 | Composition for antioxidant or improving skin wrinkle comprising fermented Cudrania tricuspidata extract |
KR20200008977A (en) * | 2018-07-17 | 2020-01-29 | 서울대학교산학협력단 | Composition for preventing, treating sarcopenia or muscle strengthening containing a fermented soybean |
KR20200008978A (en) * | 2018-07-17 | 2020-01-29 | 서울대학교산학협력단 | Composition for enhancing immune function containing a fermented soybean |
-
2020
- 2020-03-12 KR KR1020200030880A patent/KR102171334B1/en active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130027942A (en) * | 2011-09-08 | 2013-03-18 | (주)지에프씨 | Cosmetic composition comprising fermented extract of ilex paraguayensis |
KR20130096604A (en) * | 2012-02-22 | 2013-08-30 | 아담휴 주식회사 | Making method of facial moisturizer |
KR20180071721A (en) * | 2016-12-20 | 2018-06-28 | 경북대학교 산학협력단 | Composition for antioxidant or improving skin wrinkle comprising fermented Cudrania tricuspidata extract |
KR20200008977A (en) * | 2018-07-17 | 2020-01-29 | 서울대학교산학협력단 | Composition for preventing, treating sarcopenia or muscle strengthening containing a fermented soybean |
KR20200008978A (en) * | 2018-07-17 | 2020-01-29 | 서울대학교산학협력단 | Composition for enhancing immune function containing a fermented soybean |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230037108A (en) * | 2021-09-08 | 2023-03-16 | 코스맥스 주식회사 | Bifidobacterium animalis subsp. lactis strain and its use for improving skin conditions |
KR102558085B1 (en) | 2021-09-08 | 2023-07-24 | 코스맥스 주식회사 | Bifidobacterium animalis subsp. lactis strain and its use for improving skin conditions |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102153414B1 (en) | Composition for improving hair loss and promoting hair growth containing a fermented soybean | |
KR102216651B1 (en) | composition for preventing neurological diseases and improving memory containing a fermented soybeans | |
KR102171334B1 (en) | Composition for improving skin condition containing a fermented soybean | |
KR101889647B1 (en) | Novel Lactobacillus Harbinensis and Use thereof | |
JP6778026B2 (en) | Whitening agents and whitening foods and drinks containing 4'-demethylnobiletin as an active ingredient | |
KR101474998B1 (en) | Composition comprising extracts of white tea for the care of skin wrinkle | |
KR102355143B1 (en) | Method for preparing fermentated ziziphus jujuba seed | |
KR20220077991A (en) | Composition for anti-inflammation and anti-wrinkle comprising fermentative product of Gryllus bimaculatus extract as effective component | |
KR102014312B1 (en) | Skin-whitening functional composition including polyopes affinis extracts | |
KR102275055B1 (en) | Composition comprising scutellaria alpina extract | |
KR102453568B1 (en) | Composition for moisturizing and anti-inflammation comprising fermented Codium fragile extract fermented by inoculating Bacillus safensis strain | |
KR102561258B1 (en) | Composition for controlling sebum and improving pore comprising Jasminum Officinale, Salix Alba (willow) bark and Solanum melogena fruit extract | |
KR101960571B1 (en) | Method for preparing apricot extract, the apricot extract prepared therefrom, and skin care or cosmetic composition comprising the apricot extract | |
KR20160060834A (en) | Compositions for culture media of Kefir grain comprising plant extract and compositions for improving skin conditions comprising fermented products using the same | |
KR101685829B1 (en) | Method for prepareing fermented extract of mistletoe having enhanced antioxidative effect | |
KR101487942B1 (en) | The method for manufacturing panax ginseng composite by using the punica granatum concentrate for skin whitening, and the panax ginseng composite made by the method | |
KR102212343B1 (en) | Composition for skin anti-aging or moisturization comprising extract of marian plum | |
KR102666051B1 (en) | Orthosiphon Aristatus fermented product and uses thereof | |
KR20160001950A (en) | Composition for skin whitening comprising scutellaria alpina extract | |
JP7262319B2 (en) | Melanin production inhibitor and method for producing melanin production inhibitor | |
KR102355138B1 (en) | Composition for whitening or anti-wrinkle of the skin comprising fermentated ziziphus jujuba seed as effective component | |
KR102401490B1 (en) | Compositions containing Angelica gigas extract | |
WO2024117771A1 (en) | Composition including colored rice extract as active ingredient for prevention, reduction, or treatment of skin wrinkles | |
KR20180104960A (en) | Composition comprising extracts of banana, cherry, and walnut for anti-skin aging | |
KR102012170B1 (en) | Composition comprising extracts of banana, cherry, and walnut for anti-skin aging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AMND | Amendment | ||
X091 | Application refused [patent] | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |